Stock, Nicholas Simon,CHEN, Austin Chih-Yu,Bravo, Yalda Mostofi,Jacintho, Jason Duarte,Baccei, Jill Melissa,Stearns, Brian Andrew,Clark, Ryan Christopher
申请号：
AU2013363398
公开号：
AU2013363398B2
申请日:
2013.12.10
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula I, or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a therapeutically effective amount of a selective PPARa antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections.
